MED-EL has released a short video Moment of Hearing, which highlights some of the most important times when hearing is important. The link includes a self-assessment hearing test, as well as links to connect with MED-EL.
Cochlear has started the obsolescence process for the Nucleus® 5 processor. This email was sent to current N5 users by Cochlear Americas. Currently, this applies only to recipients in the United States.
“Our promise of “Hear now. And always” means we strive to bring you improved sound processor technologies and services designed to help you hear moments that matter most to you.
The Nucleus® 5 Sound Processor has been in the market for nearly eight years. This means that the sound processor is reaching its end of life; hence, we begin the obsolescence process. Our records indicate that you may currently use a Nucleus® 5 Sound Processor as either your primary or back-up sound processor. Please make note of the following milestones:
End of Sale – Effective immediately, the sound processor is no longer available for purchase. Aftermarket components and accessories such as coils and cables will remain available for purchase contingent upon supply levels until June 30, 2018.
Repair Services – Cochlear will continue to repair the sound processor through June 30, 2018. All repair warranties will end on June 30, 2018.
End of Life – The sound processor is no longer supported after June 30, 2018. This means that if your Nucleus® 5 Sound Processor stops working, Cochlear cannot repair it. Or if you lose a part or accessory, Cochlear cannot replace it.”
MED-EL’s Inside Story videos of the latest developments in the CI world are now available on MED-EL’s Facebook page.
Learn about MED-EL’s accomplishments with MRI, and what to expect from the world’s largest conference on cochlear implants and developments in the .
Three giants in the field of cochlear implant research have received the prestigious 2013 Lasker~DeBakey Clinical Medical Research award for the development of the modern cochlear implant.
Graeme Clark, whose efforts led to the commercially available implants at Cochlear Ltd, and Ingeborg Hochmair, whose parallel efforts led to the MED-EL Corporation’s cochlear implants, have relentlessly pursued the monumental engineering and biological challenges of creating the most successful neural prosthesis by far.
While the original multi-channel cochlear implants afforded most recipients access to sound, many still needed to rely on contextual or visual cues to understand speech. These early implants were marvels of engineering, science, and biotechnology. However, without advanced stimulation protocols, they were like powerful computers without software that fully exploited their capabilities.
Blake Wilson and colleagues developed a new stimulation protocol comprising a number of key elements. This method, known as CIS (Continuous Interleaved Sampling) provided an immediate and dramatic improvement in cochlear implant performance, and is the basis for stimulation in all modern cochlear implants.
Early in the process of exploring different protocols (funded primarily by the National Institutes of Health), Blake Wilson’s team at Research Triangle Institute in North Carolina recommended that the results from the research be donated to the public domain, forgoing potentially enormous personal and organizational royalties and other income. This supremely altruistic choice enabled as many people as possible to achieve maximum benefit from cochlear implants. Given that the cumulative global sales of cochlear implants is on the order of ten billion dollars, Wilson’s own estimate of the cost of that decision in the tens of millions appears to be quite conservative.
Indeed, without this one selfless act, cochlear implants would not have become nearly as effective or widespread, and outcomes would not even come close to what we can expect from a modern cochlear implant.
Without volunteer test subjects, none of the research would have been possible. Many cochlear implant users have donated countless hours to research. These efforts continue today, and are always rewarded with gratitude from the researchers.
To explore different stimulation protocols, the researcher would prefer to have direct access to the individual electrodes. Today’s cochlear implants are quite sophisticated, and interpose a significant amount of electronics between the external interface and the actual electrodes.
Much of the testing during the development of CIS was conducted with subjects implanted with the Ineraid device. This implant had a percutaneous connector, ideal for applying experimental stimulation strategies. The Ineraid device is no longer manufactured.
Compressed Analog, one of the more straightforward early strategies available prior to CIS, compresses the wide dynamic range of sound into the more limited electrical dynamic range needed for electrical stimulation. The signal is then split it into frequency bands to be presented to the individual electrodes.
This method mimics the natural hearing process, although the number of electrodes is minuscule compared to the number of hair cells in the cochlea. The thought behind the CA strategy is to present the brain with as much information as possible, and to rely on the brain to process this rich information set.
Because all electrodes are stimulated continuously and simultaneously, uncontrolled interactions between channels degrade performance.
In order to reduce interaction between channels, the electrodes may be stimulated at different times. Each electrode presents a pulse proportional to the signal strength in that channel. Because only one electrode is stimulated at any given time, channel interactions are greatly decreased.
Applying this Interleaved Protocol at a much higher rate for the whole array of electrodes is a key feature of CIS.
Other early strategies included feature extraction, which attempted to present primarily the important parts of sound for speech comprehension. Eventually it was determined that presenting as much information as possible, and letting the brain sort out the speech, proved to engender the best performance of the different approaches.
CIS is a combination of new and existing elements, which when used together, dramatically improve the performance of subjects using cochlear implants. Rather than a pre-packaged library of software, CIS is implemented in a custom manner for each cochlear implant system. All modern protocols are based on CIS, with various enhancements and refinements. The elements of CIS include:
- Full representation of the frequency range corresponding to speech and other sound
- No feature extraction to figure out what may represent important sounds for speech comprehension
- Non-simultaneous biphasic stimulation reduces interaction between electrodes
- Envelope detector filter cutoff frequencies in the 200-400 Hz range to include voice fundamental frequencies
- High stimulation rate relative to the envelope bandwidth more accurately represents channel envelopes
- Use of current sources rather than voltage sources for more accurate stimulation
- At least four electrodes to enable stimulation at different parts of the cochlea sensitive to different frequencies
According to the Lasker~DeBakey Clinical Medical Research Award Description, ‘…Wilson’s “continuous interleaved sampling” (CIS) system has allowed the majority of cochlear implant recipients—for the first time—to understand words and sentences with no visual cues. CIS supplies the basis for the sound-processing strategies that are now widespread and fueled an exponential growth in implant use that began in the early 1990s. Its rapid introduction, utilization, and dissemination stemmed in large part from a policy that donates to the public domain all intellectual property produced by Wilson and his colleagues from their NIH-funded cochlear-implant research.’
The global cochlear implant community, and indeed society as a whole, owe Blake Wilson a tremendous debt of gratitude for his seminal contributions to the field.